​

Ardelyx (ARDX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARDX Stock Forecast

Ardelyx (ARDX) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $11.00, with a high of $14.00 and a low of $8.00. This represents a 128.22% increase from the last price of $4.82.

$4 $6 $8 $10 $12 $14 High: $14 Avg: $11 Low: $8 Last Closed Price: $4.82

ARDX Stock Rating

Ardelyx stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 1 Strong Buy (7.14%), 11 Buy (78.57%), 2 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 2 11 1 Strong Sell Sell Hold Buy Strong Buy

ARDX Price Target Upside V Benchmarks

TypeNameUpside
StockArdelyx128.22%
SectorHealthcare Stocks 35.94%
IndustryBiotech Stocks 83.61%

Price Target Trends

1M3M12M
# Anlaysts-15
Avg Price Target-$14.00$11.60
Last Closing Price$4.82$4.82$4.82
Upside/Downside-190.46%140.66%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-92--11
Mar, 25-72--9
Feb, 25-82--10
Jan, 25-83--11
Dec, 24-82--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 04, 2025BTIG$14.00$5.41158.78%190.46%
Jan 02, 2025Dennis DingJefferies$8.00$5.1256.25%65.98%
Aug 05, 2024Ed ArceH.C. Wainwright$11.00$6.0581.82%128.22%
Jul 05, 2024Ed ArceH.C. Wainwright$10.00$5.2989.04%107.47%
May 24, 2024Christopher RaymondRaymond James$15.00$7.20108.33%211.20%
Dec 18, 2023Ryan DeschnerRaymond James$12.00$6.3190.17%148.96%
Dec 30, 2022Citigroup$7.00$2.85145.61%45.23%
Dec 29, 2022Laura ChicoWedbush$2.00$2.34-14.53%-58.51%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 07, 2025ScotiabankOutperforminitialise
Jan 02, 2025JefferiesBuyBuyhold
Aug 05, 2024H.C. WainwrightBuyBuyhold
Aug 02, 2024WedbushBuyBuyhold
Jul 05, 2024H.C. WainwrightBuyBuyhold
Jul 02, 2024Piper SandlerOverweightNeutraldowngrade
Jun 20, 2024WedbushBuyBuyhold
May 24, 2024Piper SandlerOverweightOverweighthold
May 24, 2024WedbushBuyBuyhold
May 03, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.05$-1.52$-0.42$-0.30$-0.17----
Avg Forecast$-1.00$-1.51$-0.51$-0.27$-0.17$-0.14$0.40$0.84$1.21
High Forecast$-0.77$-1.17$-0.39$-0.21$-0.12$0.38$0.93$1.34$1.52
Low Forecast$-1.26$-1.92$-0.70$-0.30$-0.23$-0.45$0.04$0.47$1.03
Surprise %5.00%0.66%-17.65%11.11%-----

Revenue Forecast

$0 $200M $400M $600M $800M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.57M$10.10M$52.16M$124.46M$333.62M----
Avg Forecast$6.92M$9.75M$34.15M$124.20M$327.18M$374.66M$503.68M$650.81M$797.50M
High Forecast$8.34M$11.74M$44.16M$127.81M$341.44M$410.26M$512.36M$669.84M$952.97M
Low Forecast$5.71M$8.04M$28.01M$122.28M$314.26M$342.01M$495.00M$631.79M$704.65M
Surprise %9.36%3.56%52.74%0.20%1.97%----

Net Income Forecast

$-300M $-170M $-40M $90M $220M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-94.31M$-158.16M$-67.21M$-66.07M$-39.14M----
Avg Forecast$-219.06M$-135.94M$-138.92M$-66.07M$-38.82M$-45.84M$83.22M$207.57M$265.76M
High Forecast$-169.11M$-108.75M$-111.14M$-52.85M$-26.62M$83.49M$204.48M$294.88M$333.11M
Low Forecast$-277.26M$-163.13M$-166.71M$-79.28M$-51.03M$-98.10M$8.18M$103.80M$225.54M
Surprise %-56.95%16.35%-51.62%0.00%0.80%----

ARDX Forecast FAQ

Is Ardelyx stock a buy?

Ardelyx stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 11 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Ardelyx is a favorable investment for most analysts.

What is Ardelyx's price target?

Ardelyx's price target, set by 14 Wall Street analysts, averages $11 over the next 12 months. The price target range spans from $8 at the low end to $14 at the high end, suggesting a potential 128.22% change from the previous closing price of $4.82.

How does Ardelyx stock forecast compare to its benchmarks?

Ardelyx's stock forecast shows a 128.22% upside, outperforming the average forecast for the healthcare stocks sector (35.94%) and outperforming the biotech stocks industry (83.61%).

What is the breakdown of analyst ratings for Ardelyx over the past three months?

  • April 2025: 0% Strong Buy, 81.82% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 77.78% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is Ardelyx’s EPS forecast?

Ardelyx's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.14, marking a -17.65% decrease from the reported $-0.17 in 2024. Estimates for the following years are $0.4 in 2026, $0.84 in 2027, and $1.21 in 2028.

What is Ardelyx’s revenue forecast?

Ardelyx's average annual revenue forecast for its fiscal year ending in December 2025 is $374.66M, reflecting a 12.30% increase from the reported $333.62M in 2024. The forecast for 2026 is $503.68M, followed by $650.81M for 2027, and $797.5M for 2028.

What is Ardelyx’s net income forecast?

Ardelyx's net income forecast for the fiscal year ending in December 2025 stands at $-45.835M, representing an 17.12% increase from the reported $-39.136M in 2024. Projections indicate $83.22M in 2026, $207.57M in 2027, and $265.76M in 2028.